CN113144281B - 一种伤口创面消毒凝胶及其制备方法 - Google Patents
一种伤口创面消毒凝胶及其制备方法 Download PDFInfo
- Publication number
- CN113144281B CN113144281B CN202110419386.XA CN202110419386A CN113144281B CN 113144281 B CN113144281 B CN 113144281B CN 202110419386 A CN202110419386 A CN 202110419386A CN 113144281 B CN113144281 B CN 113144281B
- Authority
- CN
- China
- Prior art keywords
- wound
- sodium hyaluronate
- wound surface
- gel
- chitosan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000004659 sterilization and disinfection Methods 0.000 title claims abstract description 73
- 238000002360 preparation method Methods 0.000 title abstract description 11
- 238000001879 gelation Methods 0.000 title description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 61
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 61
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 61
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims abstract description 53
- 239000011630 iodine Substances 0.000 claims abstract description 53
- 229910052740 iodine Inorganic materials 0.000 claims abstract description 53
- 229920001661 Chitosan Polymers 0.000 claims abstract description 44
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims abstract description 34
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims abstract description 34
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims abstract description 34
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims abstract description 20
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 20
- 229940005550 sodium alginate Drugs 0.000 claims abstract description 20
- 239000000661 sodium alginate Substances 0.000 claims abstract description 20
- 239000008367 deionised water Substances 0.000 claims abstract description 12
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 36
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 claims description 30
- 238000003756 stirring Methods 0.000 claims description 21
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 18
- 229960000458 allantoin Drugs 0.000 claims description 18
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 12
- 235000019445 benzyl alcohol Nutrition 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 7
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 6
- 229920003081 Povidone K 30 Polymers 0.000 claims description 6
- 230000000249 desinfective effect Effects 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 229920003082 Povidone K 90 Polymers 0.000 claims description 4
- 229940045110 chitosan Drugs 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 2
- 229960004217 benzyl alcohol Drugs 0.000 claims 1
- 238000011012 sanitization Methods 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 abstract description 75
- 206010052428 Wound Diseases 0.000 abstract description 74
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 40
- 230000035876 healing Effects 0.000 abstract description 14
- 230000029663 wound healing Effects 0.000 abstract description 12
- 208000015181 infectious disease Diseases 0.000 abstract description 7
- 230000007423 decrease Effects 0.000 abstract description 6
- 238000001179 sorption measurement Methods 0.000 abstract description 6
- 231100000252 nontoxic Toxicity 0.000 abstract description 4
- 230000003000 nontoxic effect Effects 0.000 abstract description 4
- 206010022998 Irritability Diseases 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 230000002688 persistence Effects 0.000 abstract 1
- 230000037314 wound repair Effects 0.000 abstract 1
- 239000000499 gel Substances 0.000 description 71
- 230000000052 comparative effect Effects 0.000 description 25
- 238000012360 testing method Methods 0.000 description 21
- 230000009467 reduction Effects 0.000 description 14
- 230000000694 effects Effects 0.000 description 10
- 238000011056 performance test Methods 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 230000001954 sterilising effect Effects 0.000 description 9
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 8
- 239000002994 raw material Substances 0.000 description 8
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 8
- 235000019345 sodium thiosulphate Nutrition 0.000 description 8
- 238000004448 titration Methods 0.000 description 8
- 206010039509 Scab Diseases 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 6
- 241000222122 Candida albicans Species 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 5
- 210000003491 skin Anatomy 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 229940095731 candida albicans Drugs 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000000536 complexating effect Effects 0.000 description 4
- 230000006806 disease prevention Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000007794 irritation Effects 0.000 description 4
- 239000003094 microcapsule Substances 0.000 description 4
- 230000003472 neutralizing effect Effects 0.000 description 4
- 229910052709 silver Inorganic materials 0.000 description 4
- 239000004332 silver Substances 0.000 description 4
- 231100000460 acute oral toxicity Toxicity 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- -1 silver ions Chemical class 0.000 description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 241000283977 Oryctolagus Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 238000010668 complexation reaction Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 239000002085 irritant Substances 0.000 description 2
- 231100000021 irritant Toxicity 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 231100000344 non-irritating Toxicity 0.000 description 2
- 239000003973 paint Substances 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010015946 Eye irritation Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 206010027439 Metal poisoning Diseases 0.000 description 1
- 229920000153 Povidone-iodine Polymers 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000023753 dehiscence Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 231100000013 eye irritation Toxicity 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 208000010501 heavy metal poisoning Diseases 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 229960001621 povidone-iodine Drugs 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0014—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0004—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0023—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/008—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/106—Halogens or compounds thereof, e.g. iodine, chlorite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110419386.XA CN113144281B (zh) | 2021-04-19 | 2021-04-19 | 一种伤口创面消毒凝胶及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110419386.XA CN113144281B (zh) | 2021-04-19 | 2021-04-19 | 一种伤口创面消毒凝胶及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113144281A CN113144281A (zh) | 2021-07-23 |
CN113144281B true CN113144281B (zh) | 2022-04-15 |
Family
ID=76868711
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110419386.XA Active CN113144281B (zh) | 2021-04-19 | 2021-04-19 | 一种伤口创面消毒凝胶及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113144281B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114129592B (zh) * | 2021-12-06 | 2023-03-10 | 郑州大学第一附属医院 | 一种用于妇产科的消毒凝胶及其制备方法 |
CN116212008A (zh) * | 2023-03-15 | 2023-06-06 | 武汉康宁美生物科技有限公司 | 一种伤口创面消毒凝胶及其制备方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6521243B2 (en) * | 2000-12-22 | 2003-02-18 | Pharma C And D, Limited | Ionic chitosan -iodine complexes: antiseptic hydrogels and wound healing promoters |
US20050191270A1 (en) * | 2004-02-27 | 2005-09-01 | Hydromer, Inc. | Anti-infectious hydrogel compositions |
CN1302813C (zh) * | 2004-12-29 | 2007-03-07 | 中国海洋大学 | 含海藻糖和透明质酸的烧伤用药传递系统及其制备方法 |
CN101524366B (zh) * | 2009-03-21 | 2011-06-08 | 刘维峰 | 一种复方生物活性消毒液的制备方法 |
CN103432160A (zh) * | 2013-08-16 | 2013-12-11 | 江苏省健尔康医用敷料有限公司 | 一种广谱触杀型医用手术灌洗液及其制备方法 |
US10400339B2 (en) * | 2013-09-23 | 2019-09-03 | Agienic, Inc. | Low water solubility compositions for use in corrosion protection |
CN104739858A (zh) * | 2015-01-14 | 2015-07-01 | 深圳市安多福消毒高科技股份有限公司 | 隔离膏及其制备方法 |
CN105557751B (zh) * | 2015-05-18 | 2018-08-07 | 深圳市安多福动物药业有限公司 | 高分子生物有机碘及其制备方法、水产养殖疾病防治方法 |
CN105641733A (zh) * | 2015-12-29 | 2016-06-08 | 山东康力医疗器械科技有限公司 | 一种复合抗菌止血敷料的制备方法 |
CN107823216A (zh) * | 2017-11-16 | 2018-03-23 | 李雪红 | 一种新型灌洗液制剂 |
CN108187132A (zh) * | 2018-01-05 | 2018-06-22 | 广州润虹医药科技股份有限公司 | 一种聚维酮碘水凝胶抗菌敷料及其制备方法 |
CN108721328B (zh) * | 2018-06-09 | 2020-12-01 | 江苏海尔滋生物科技有限公司 | 几丁聚糖碘生物材料及其制备方法 |
CN108653201B (zh) * | 2018-06-11 | 2021-05-14 | 佛山市南海东方澳龙制药有限公司 | 防滴漏型聚维酮碘溶液及其制备方法 |
CN108837149B (zh) * | 2018-09-14 | 2021-11-30 | 广州润虹医药科技股份有限公司 | 一种具有创面修复功能的组合物 |
CN109833331B (zh) * | 2019-04-09 | 2022-09-16 | 上海创宏生物科技有限公司 | 一种杀灭猪肺炎支原体的制剂及其制备方法 |
CN110013472A (zh) * | 2019-04-30 | 2019-07-16 | 扬州大学 | 一种奶牛乳头成膜药浴剂、其制备方法及其使用方法 |
-
2021
- 2021-04-19 CN CN202110419386.XA patent/CN113144281B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN113144281A (zh) | 2021-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2944592T3 (es) | Composición para un apósito para heridas | |
KR102608165B1 (ko) | 상처 처치제용 조성물 | |
CN1089587C (zh) | 稳定的交联聚乙烯吡咯烷酮和碘的配合物以及制备该配合物的方法 | |
CN113144281B (zh) | 一种伤口创面消毒凝胶及其制备方法 | |
KR20170107012A (ko) | 상처 처치제용 조성물 | |
JPH08510454A (ja) | 抗感染症薬剤 | |
CN108187132A (zh) | 一种聚维酮碘水凝胶抗菌敷料及其制备方法 | |
AU2017259304B2 (en) | Anti-microbial compositions | |
US6521243B2 (en) | Ionic chitosan -iodine complexes: antiseptic hydrogels and wound healing promoters | |
CN111991417A (zh) | 一种具有生理响应性的次氯酸凝胶及其在皮肤创面中的应用 | |
CN110198731B (zh) | 包含二巯基丙磺酸钠和二甲亚砜的抗菌剂组合物、所述组合物的用途和使用其的伤口处理方法 | |
CN109620842B (zh) | 交联聚乙烯吡咯烷酮和碘的络合物及其制备方法与应用 | |
KR102503193B1 (ko) | 버섯 또는 진균 유래 키토산, 또는 그 유도체를 이용한 하이드로겔 및 그 제조방법 | |
CN108721328B (zh) | 几丁聚糖碘生物材料及其制备方法 | |
EP3849514A1 (en) | A composition for use in the prevention and/or treatment of epistaxis | |
CN106668062A (zh) | 药物组合物、其在制备用于伤口愈合的药物中的应用、医药制剂及医药绷带 | |
US11744249B2 (en) | Disinfectants with iodine and copper complexes for use against coronavirus | |
US20230389553A1 (en) | Disinfectants with iodine and copper complexes for biofilm eradication and prevention | |
KR20230112488A (ko) | 성상 안정성이 확보된 포비돈요오드와 트리메틸키토산을 함유하는 3중복합 창상피복재의 제조방법 | |
RU2775940C2 (ru) | Композиция для раневых повязок | |
HU221676B1 (hu) | Gyógyászati készítmény, amely hatóanyagként jódot és ezüst-nitrátot tartalmazó etanolos, vagy vizes-etanolos oldatokból áll és eljárás az előállítására |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20220302 Address after: 518000 floors 1-4, No.7 factory building, Beishan Industrial Zone, Yantian District, Shenzhen City, Guangdong Province Applicant after: SHENZHEN ANDUOFU DISINFECTION HIGH-TECH Co.,Ltd. Address before: 518000 floors 1-4, No.7 factory building, Beishan Industrial Zone, Yantian District, Shenzhen City, Guangdong Province Applicant before: SHENZHEN ANDUOFU DISINFECTION HIGH-TECH Co.,Ltd. Applicant before: Shenzhen andofu Animal Pharmaceutical Co., Ltd |
|
GR01 | Patent grant | ||
GR01 | Patent grant |